Ultrasmall Porous Silica Nanoparticles with Enhanced Pharmacokinetics for Cancer Theranostics
- 24 May 2021
- journal article
- letter
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 21 (11) , 4692-4699
Abstract
Theranostic nanoparticles hold the potential to greatly improve cancer management by providing personalized medicine. Although many theranostic nanoconstructs have been successful in preclinical studies, clinical translation is still hampered by their limited targeting capability and lack of successful therapeutic efficacy. We report the use of novel ultrasmall porous silica nanoparticles (UPSN) with enhanced in vivo pharmacokinetics such as high target tissue accumulation (12% ID/g in the tumor) and evasion from the reticuloendothelial system (RES) organs. Herein, UPSN is conjugated with the isotopic pair 90/86Y, enabling both noninvasive imaging as well as internal radiotherapy. In vivo PET imaging demonstrates prolonged blood circulation and excellent tumor contrast with 86Y-DOTA-UPSN. Tumor-to-muscle and tumor-to-liver uptake values were significantly high (12.4 ± 1.7 and 1.5 ± 0.5, respectively), unprecedented for inorganic nanomaterials. 90Y-DOTA-UPSN significantly inhibits tumor growth and increases overall survival, indicating the promise of UPSN for future clinical translation as a cancer theranostic agent.Keywords
Funding Information
- National Cancer Institute (P30CA014520)
- Conselho Nacional de Desenvolvimento Cient??fico e Tecnol??gico
This publication has 32 references indexed in Scilit:
- Cancer Theranostics2014
- Analysis on the current status of targeted drug delivery to tumorsJournal of Controlled Release, 2012
- Ultrasmall Sub-10 nm Near-Infrared Fluorescent Mesoporous Silica NanoparticlesJournal of the American Chemical Society, 2012
- Yttrium-90 (90Y) in the principal radionuclide therapies: An efficacy correlation between peptide receptor radionuclide therapy, radioimmunotherapy and transarterial radioembolization therapy. Ten years of experience (1999–2009)Critical Reviews in Oncology/Hematology, 2011
- Cancer-Targeted Optical Imaging with Fluorescent Zinc Oxide NanowiresNano Letters, 2011
- Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanomaJournal of Clinical Investigation, 2011
- Tracking of Multimodal Therapeutic Nanocomplexes Targeting Breast Cancer in VivoNano Letters, 2010
- Graphene in Mice: Ultrahigh In Vivo Tumor Uptake and Efficient Photothermal TherapyNano Letters, 2010
- Fluorescent Silica Nanoparticles with Efficient Urinary Excretion for NanomedicineNano Letters, 2008
- Clearance Properties of Nano-Sized Particles and Molecules as Imaging Agents: Considerations and CaveatsNanomedicine, 2008